期刊文献+

甲状腺全切除术在分化型甲状腺癌外科治疗中的应用价值 被引量:49

Application Value of Total Thyroidectomy in the Surgical Treatment of Differentiated Thyroid Cancer
下载PDF
导出
摘要 目的探讨甲状腺全切除术在甲状腺癌外科治疗中的应用价值。方法对60例分化型甲状腺癌患者的临床资料进行回顾性分析和总结,其中采用甲状腺全切除术的患者48例,采用甲状腺次全切除术的患者12例。结果48例进行甲状腺全切除术的患者术后发生低钙及声嘶5例(10.42%),1年间甲状腺癌复发1例(2.08%);12例采用甲状腺次全切除术的患者术后发生低钙及声嘶6例(50.00%),1年间甲状腺癌复发5例(41.67%)。采用甲状腺次全切除术治疗的患者更易出现术后并发症(P=0.042),且1年间甲状腺癌的复发率更高。结论甲状腺全切除术是治疗分化型甲状腺癌的一种有效方式,但采用甲状腺全切除术对患者进行治疗时要预防并发症的发生。 Objective To investigate the application value of total thyroidectomy in the surgical treatment of differentiated thyroid cancer. Methods 60 cases of differentiated thyroid cancer were retrospectively analyzed and summarized,48 patients received total thyroidectomy, and 12 patients subtotal thyroidectomy. Results In 48 cases treated with total thyroidectomy,5 cases (10.42% )had postoperative hypocalcemia and hoarseness, 1- year recurrence of thyroid cancer was 1 cases (2.08 % ) ;in 12 cases treated with subtotal thyroidectomy ,6 cases(50.00% ) had hypocalcemia and hoarseness, 1-year recurrence of thyroid cancer was 5 cases(41.67% );patients treated with total thyroidectomy were more likely to have postoperative complications (P = 0.042). 1- year recurrence of thyroid cancer was higher. Conclusion The total thyroidectomy is an effective way to treat differentiated thyroid cancer, but we should prevent occurrence of complications in clinic.
机构地区 解放军
出处 《实用癌症杂志》 2017年第7期1214-1215,共2页 The Practical Journal of Cancer
关键词 甲状腺全切除 分化型甲状腺癌 并发症 外科治疗 甲状腺次全切除 Total thyroidectomy Differentiated thyroid carcinoma Complication Surgical treatment Subtotal thyroidectomy
  • 相关文献

参考文献7

二级参考文献68

  • 1孔凡民,王春声,李航宇,李昱骥,隋春阳,周建平,董明,田雨霖,郭克建,郭仁宣.甲状腺良性病变术中损伤喉返神经的原因及预防(附2266例分析)[J].中国实用外科杂志,2006,26(3):209-210. 被引量:76
  • 2陈红云,郭百锁,温新平,程晓天,张慧芳.2000—2005年山西省碘缺乏病实验室外质控网络运行情况分析[J].地方病通报,2006,21(1):62-63. 被引量:4
  • 3杨卫平,邵堂雷,丁家增,金筱泰,严佶祺,马迪.双侧结节性甲状腺肿手术切除范围的探讨[J].中国实用外科杂志,2007,27(5):403-405. 被引量:58
  • 4Hazard JB, Hawk WA, Crile GJ. Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity. J Clin Endocrinol Metab 1959; 19:152-161.
  • 5Schroder S, Holl K, Padberg BC. Pathology of sporadic and hereditary medullary thyroid carcinoma. In: Raue F, eds. Medullary thyroid carcinoma. New York: Springer-Verlag; 1992: 19-45.
  • 6Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary throid cancer. Oncotogist 2008; 13: 539-547.
  • 7You YN, Lakhani V, Wells SA Jr, Moley JF. Medullary thyroid cancer. Surg Oncol Clin N Am 2006; 15: 639-660.
  • 8Hegedus L, Karstrup S. Ultrasonography in the evaluation of cold thyroid nodules. Eur J Endocrinol 1998; 138:30-31.
  • 9Sailer B, Moeller L, Gorges R, Janssen OE, Mann K. Role of conventional ultrasound and color Doppler sonography in the diagnosis of medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes 2002; 110: 403-407.
  • 10Gorman B, Charboneau JW, James EM, Reading CC, Wold LE, Grant CS, et al. Medullary thyroid carcinoma: role of high-resolution US. Radiology 1987; 62: 147-150.

共引文献178

同被引文献334

引证文献49

二级引证文献199

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部